Arrowhead Pharmaceuticals
ARWR
#2032
Rank
HK$74.18 B
Marketcap
HK$536.60
Share price
1.23%
Change (1 day)
249.55%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -HK$9.83

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$9.72. In 2024 the company made an earnings per share (EPS) of -HK$38.88 a decrease over its 2023 EPS that were of -HK$14.88.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$9.83-74.72%
2024-HK$38.88161.39%
2023-HK$14.8817.36%
2022-HK$12.6819.85%
2021-HK$10.5861.9%
2020-HK$6.53-216.67%
2019HK$5.60-210.77%
2018-HK$5.0538.3%
2017-HK$3.66-64.93%
2016-HK$10.42-16.25%
2015-HK$12.4428%
2014-HK$9.72-3.85%
2013-HK$10.11-31.58%
2012-HK$14.78331.82%
2011-HK$3.42-51.11%
2010-HK$7.00-79.07%
2009-HK$33.44-37.68%
2008-HK$53.66-16.87%
2007-HK$64.5538.33%
2006-HK$46.66122.22%
2005-HK$21.0042.11%
2004-HK$14.78533.33%
2003-HK$2.33-99.08%
2002-HK$252.4925%
2001-HK$202.0033.33%
2000-HK$151.50-120%
1999HK$757.48-400%
1998-HK$252.49-81.48%
1997-HK$1,363

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
HK$0.70-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.59-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$22.40 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.19-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$62.76 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA